共 31 条
- [21] ANTIALLERGIC EFFECTS OF THE NEW HISTAMINE H1-RECEPTOR ANTAGONIST TAZIFYLLINE IN HEALTHY ATOPIC AND NON-ATOPIC SUBJECTS ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 1988, 38-1 (02): : 308 - 311
- [24] Modeling time-delayed concentration-QT effects with ACT-1014-6470, a novel oral complement factor 5a receptor 1 (C5a1 receptor) antagonist PHARMACOLOGY RESEARCH & PERSPECTIVES, 2023, 11 (04):
- [25] Central effects of fexofenadine and cetirizine:: Measurement of psychomotor performance, subjective sleepiness, and brain histamine H1-receptor occupancy using 11C-doxepin positron emission tomography JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 44 (08): : 890 - 900
- [27] General pharmacological properties of the new angiotensin II receptor antagonist (+/-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]1H-benzimidazole-7-carboxylate .1. Effects on central nervous system and other properties ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 1996, 46 (06): : 572 - 579
- [28] Old and New Pharmacology: Positive Allosteric Modulation of the α7 Nicotinic Acetylcholine Receptor by the 5-Hydroxytryptamine2B/C Receptor Antagonist SB-206553 (3,5-Dihydro-5-methyl-N-3-pyridinylbenzo[1,2-b:4,5-b′]di pyrrole-1(2H)-carboxamide) JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 328 (03): : 766 - 776
- [29] EFFECTS OF THE NEW H-2-RECEPTOR ANTAGONIST 3-AMINO-4-[4-[4-(1-PIPERIDINOMETHYL)-2-PYRIDYLOXY]-CIS-2-BUTENYLAMINO]-3-CYCLOBUTENE-1,2-DIONE HYDROCHLORIDE ON GASTRIC-ACID SECRETION AND ULCERATION ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1990, 40-1 (01): : 49 - 54
- [30] Effects of the new angiotensin receptor antagonist dipotassium (Z)-2-[[5-ethyl-3-[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl-1,3,4-thiadiazoline-2-ylidene]aminocarbonyl]-1-cyclopentencarboxylate on experimental cardiac hypertrophy and acute left ventricular failure ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 1997, 47 (10): : 1099 - 1103